http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005226492-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_497f2c512645fbb604f64f16c17a6e51
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30148
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G03F1-84
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03F1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-00
filingDate 2004-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97afbfd896fe35f01731c3fda4f3447f
publicationDate 2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2005226492-A1
titleOfInvention Acceptable defect positioning and manufacturing method for large-scaled photomask blanks
abstract Disclosed is an acceptable defect positioning and manufacturing method for large-scaled photomask blanks, where the defective information of the entire large-scaled photomask blanks or etched and to-be-repaired photomask, upon being acquired by a photomask inspection apparatus, is categorized into a critical area a non-critical area. The so-called critical area is directed to areas where defects are unacceptable, while the non-critical area is directed to areas where defects are acceptable. For large-scaled photomask blanks, if all defects are within the non-critical area, the photomask blanks are deemed acceptable. For large-scaled photomasks, photomask acceptance system only needs to reject photomask blanks whose defects are within the critical area of the mask products.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8019333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006205398-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015198896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9538404-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7664614-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9406573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009060317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016025994-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010233594-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009119045-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008050010-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8319959-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9784986-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008002874-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I563336-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8090188-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10241347-B2
priorityDate 2004-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004043303-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4200668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004175631-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810586

Total number of triples: 37.